PLASMA MIR-323 AS A BIOMARKER FOR SCREENING PAPILLARY THYROID CANCER FROM HEALTHY CONTROLS

The present study aims to evaluate whether plasma miR-323 serves as a potential biomarker to screen patients with papillary thyroid cancer (PTC) from healthy controls.Real-time PCR was performed to evaluate miR-323 expression in healthy controls and benign thyroid nodule (BTN) and PTC patients.Receiver operating characteristic (ROC) curve analysis

Abstract BackgroundDespite evidence that regular physical activity (PA) among older adults confers numerous health and functional benefits, PA participation rates are low.Using commercially available wearable PA monitors (PAMs) is one way to augment PA promotion efforts.However, while expert recommendations exist for the specific information needed